Quintiles extends data management expertise and capabilities to China

USA-headquartered biopharmaceutical services major Quintiles has announced the expansion of its data management services into Shanghai, China, aiming to strengthening the company's capability to serve customers in that country and the Asia-Pacific region.

'China is an integral component of the New Health landscape, quickly becoming one of the key markets for biopharmaceutical development and innovation,' said Ling Zhen, general manager, Quintiles China, noting: 'As a pioneer in the China clinical development industry, we have seen tremendous growth in demand for our services as biopharmaceutical customers look to enhance their operational efficiencies and position in this growing market.'

Lalit Pai, head of Quintiles Global Data Management, added: 'With regional data management operations in Japan, India and now China, Quintiles can continue to deliver operational efficiencies and cost-savings for our customers, while offering services in local time zones with local expertise. The Shanghai expansion will allow us to lead biometrics in China, serving local customers, as well as customers throughout Asia-Pacific.'